Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 115

1.

Identification of tumor-initiating cells in a canine hepatocellular carcinoma cell line.

Michishita M, Ezaki S, Ogihara K, Naya Y, Azakami D, Nakagawa T, Sasaki N, Arai T, Shida T, Takahashi K.

Res Vet Sci. 2014 Apr;96(2):315-22. doi: 10.1016/j.rvsc.2014.01.004.

PMID:
24534130
2.

Cancer stem-like cells enriched with CD29 and CD44 markers exhibit molecular characteristics with epithelial-mesenchymal transition in squamous cell carcinoma.

Geng S, Guo Y, Wang Q, Li L, Wang J.

Arch Dermatol Res. 2013 Jan;305(1):35-47. doi: 10.1007/s00403-012-1260-2.

PMID:
22740085
3.

A tumor-related lymphoid progenitor population supports hierarchical tumor organization in canine B-cell lymphoma.

Ito D, Endicott MM, Jubala CM, Helm KM, Burnett RC, Husbands BD, Borgatti A, Henson MS, Burgess KE, Bell JS, Kisseberth WC, Valli VE, Cutter GR, Avery AC, Hahn KA, O'Brien TD, Modiano JF.

J Vet Intern Med. 2011 Jul-Aug;25(4):890-6. doi: 10.1111/j.1939-1676.2011.0756.x.

4.

Cancer stem/progenitor cells are highly enriched in CD133+CD44+ population in hepatocellular carcinoma.

Zhu Z, Hao X, Yan M, Yao M, Ge C, Gu J, Li J.

Int J Cancer. 2010 May 1;126(9):2067-78. doi: 10.1002/ijc.24868.

5.

Flow cytometric analysis for detection of tumor-initiating cells in feline mammary carcinoma cell lines.

Michishita M, Otsuka A, Nakahira R, Nakagawa T, Sasaki N, Arai T, Takahashi K.

Vet Immunol Immunopathol. 2013 Nov 15;156(1-2):73-81. doi: 10.1016/j.vetimm.2013.08.006.

PMID:
24041801
6.

Toll like receptor 4 facilitates invasion and migration as a cancer stem cell marker in hepatocellular carcinoma.

Liu WT, Jing YY, Yu GF, Han ZP, Yu DD, Fan QM, Ye F, Li R, Gao L, Zhao QD, Wu MC, Wei LX.

Cancer Lett. 2015 Mar 28;358(2):136-43. doi: 10.1016/j.canlet.2014.12.019.

PMID:
25511737
7.

Identification of local and circulating cancer stem cells in human liver cancer.

Yang ZF, Ngai P, Ho DW, Yu WC, Ng MN, Lau CK, Li ML, Tam KH, Lam CT, Poon RT, Fan ST.

Hepatology. 2008 Mar;47(3):919-28. doi: 10.1002/hep.22082.

PMID:
18275073
8.

Tumor-associated macrophages produce interleukin 6 and signal via STAT3 to promote expansion of human hepatocellular carcinoma stem cells.

Wan S, Zhao E, Kryczek I, Vatan L, Sadovskaya A, Ludema G, Simeone DM, Zou W, Welling TH.

Gastroenterology. 2014 Dec;147(6):1393-404. doi: 10.1053/j.gastro.2014.08.039.

9.

Gene expression profiling of liver cancer stem cells by RNA-sequencing.

Ho DW, Yang ZF, Yi K, Lam CT, Ng MN, Yu WC, Lau J, Wan T, Wang X, Yan Z, Liu H, Zhang Y, Fan ST.

PLoS One. 2012;7(5):e37159. doi: 10.1371/journal.pone.0037159.

10.

Sphere-forming cell subpopulations with cancer stem cell properties in human hepatoma cell lines.

Cao L, Zhou Y, Zhai B, Liao J, Xu W, Zhang R, Li J, Zhang Y, Chen L, Qian H, Wu M, Yin Z.

BMC Gastroenterol. 2011 Jun 14;11:71. doi: 10.1186/1471-230X-11-71.

11.

A CD90(+) tumor-initiating cell population with an aggressive signature and metastatic capacity in esophageal cancer.

Tang KH, Dai YD, Tong M, Chan YP, Kwan PS, Fu L, Qin YR, Tsao SW, Lung HL, Lung ML, Tong DK, Law S, Chan KW, Ma S, Guan XY.

Cancer Res. 2013 Apr 1;73(7):2322-32. doi: 10.1158/0008-5472.CAN-12-2991.

12.

Significance of CD90+ cancer stem cells in human liver cancer.

Yang ZF, Ho DW, Ng MN, Lau CK, Yu WC, Ngai P, Chu PW, Lam CT, Poon RT, Fan ST.

Cancer Cell. 2008 Feb;13(2):153-66. doi: 10.1016/j.ccr.2008.01.013.

13.

Clinical implications of cancer stem cell biology in hepatocellular carcinoma.

Ji J, Wang XW.

Semin Oncol. 2012 Aug;39(4):461-72. doi: 10.1053/j.seminoncol.2012.05.011. Review.

14.

The Notch pathway promotes the cancer stem cell characteristics of CD90+ cells in hepatocellular carcinoma.

Luo J, Wang P, Wang R, Wang J, Liu M, Xiong S, Li Y, Cheng B.

Oncotarget. 2016 Feb 23;7(8):9525-37. doi: 10.18632/oncotarget.6672.

15.

Tumor initiating cells in esophageal squamous cell carcinomas express high levels of CD44.

Zhao JS, Li WJ, Ge D, Zhang PJ, Li JJ, Lu CL, Ji XD, Guan DX, Gao H, Xu LY, Li EM, Soukiasian H, Koeffler HP, Wang XF, Xie D.

PLoS One. 2011;6(6):e21419. doi: 10.1371/journal.pone.0021419.

16.

Visualization of stem cell features in human hepatocellular carcinoma reveals in vivo significance of tumor-host interaction and clinical course.

Muramatsu S, Tanaka S, Mogushi K, Adikrisna R, Aihara A, Ban D, Ochiai T, Irie T, Kudo A, Nakamura N, Nakayama K, Tanaka H, Yamaoka S, Arii S.

Hepatology. 2013 Jul;58(1):218-28. doi: 10.1002/hep.26345.

PMID:
23447025
17.

Localization of CD44 and CD90 positive cells to the invasive front of breast tumors.

Donnenberg VS, Donnenberg AD, Zimmerlin L, Landreneau RJ, Bhargava R, Wetzel RA, Basse P, Brufsky AM.

Cytometry B Clin Cytom. 2010 Sep;78(5):287-301. doi: 10.1002/cyto.b.20530.

18.

Investigation of diagnostic utility and expression profiles of stem cell markers (CD133 and CD90) in hepatocellular carcinoma, small cell dysplasia, and cirrhosis.

Yilmaz G, Akyol G, Cakir A, Ilhan M.

Pathol Res Pract. 2014 Jul;210(7):419-25. doi: 10.1016/j.prp.2014.02.011.

PMID:
24702884
19.

Identification of cell surface antigen expression in canine hepatocellular carcinoma cell lines.

Fujimoto A, Neo S, Ishizuka C, Kato T, Segawa K, Kawarai S, Ogihara K, Hisasue M, Tsuchiya R.

J Vet Med Sci. 2013;75(6):831-5.

20.

Is sphere assay useful for the identification of cancer initiating cells of the ovary?

Martínez-Serrano MJ, Caballero-Baños M, Vilella R, Vidal L, Pahisa J, Martínez-Roman S.

Int J Gynecol Cancer. 2015 Jan;25(1):12-7. doi: 10.1097/IGC.0000000000000320.

PMID:
25365589

Supplemental Content

Support Center